Aadi Bioscience, Inc.
Index- P/E- EPS (ttm)-2.98 Insider Own0.30% Shs Outstand21.27M Perf Week-2.47%
Market Cap174.34M Forward P/E- EPS next Y-2.53 Insider Trans0.00% Shs Float20.64M Perf Month-34.95%
Income-62.60M PEG- EPS next Q-0.71 Inst Own63.00% Short Float / Ratio7.04% / 10.77 Perf Quarter-40.90%
Sales11.00M P/S15.85 EPS this Y-712.40% Inst Trans13.63% Short Interest1.45M Perf Half Y-49.03%
Book/sh7.95 P/B0.89 EPS next Y13.90% ROA-40.20% Target Price42.50 Perf Year-60.06%
Cash/sh7.46 P/C0.95 EPS next 5Y- ROE-46.50% 52W Range6.80 - 18.47 Perf YTD-44.58%
Dividend- P/FCF- EPS past 5Y-1.30% ROI-77.90% 52W High-61.51% Beta1.28
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin89.90% 52W Low4.56% ATR0.48
Employees76 Current Ratio10.60 Sales Q/Q- Oper. Margin- RSI (14)28.64 Volatility5.18% 7.21%
OptionableYes Debt/Eq0.00 EPS Q/Q92.60% Profit Margin- Rel Volume1.85 Prev Close7.12
ShortableYes LT Debt/Eq0.00 EarningsMar 28 BMO Payout- Avg Volume134.74K Price7.11
Recom1.60 SMA20-11.25% SMA50-31.95% SMA200-42.60% Volume243,547 Change-0.14%
Jan-11-22Initiated Jefferies Buy $45
Oct-01-21Initiated Cowen Outperform
Sep-14-21Initiated Ladenburg Thalmann Buy $51
Sep-08-21Initiated Piper Sandler Overweight $45
Mar-28-23 08:00AM
Mar-27-23 08:00AM
Mar-26-23 02:00PM
Mar-15-23 08:00AM
Mar-03-23 08:00AM
08:00AM Loading…
Feb-22-23 08:00AM
Nov-17-22 08:00AM
Nov-09-22 08:00AM
Nov-08-22 04:00PM
Nov-03-22 08:00AM
Oct-27-22 08:00AM
Oct-12-22 08:01AM
Sep-22-22 04:01PM
Sep-01-22 08:00AM
08:00AM Loading…
Aug-10-22 08:00AM
Aug-04-22 06:21AM
Jul-28-22 08:30AM
Jun-23-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
May-26-22 05:10PM
May-18-22 07:00AM
May-12-22 08:32AM
May-09-22 08:00AM
May-04-22 08:00AM
Apr-28-22 05:07PM
Apr-18-22 08:00AM
Apr-08-22 01:09PM
05:13AM Loading…
Apr-01-22 05:13AM
Mar-31-22 02:45PM
Mar-17-22 07:00AM
Mar-01-22 07:00AM
Feb-25-22 04:41AM
Feb-23-22 07:00AM
Jan-04-22 04:30PM
Dec-28-21 09:38AM
Dec-23-21 12:38PM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-27-21 06:01AM
Nov-23-21 04:22PM
Nov-15-21 08:00AM
Nov-13-21 01:35PM
Nov-10-21 07:00AM
Nov-09-21 08:00AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-22-21 08:00AM
Oct-19-21 05:22PM
Oct-06-21 08:00AM
Sep-20-21 08:30AM
Sep-13-21 08:00AM
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.